Type 1 diabetes: pregnancy planning/pregnancy/post-pregnancy
Women with type 1 diabetes who are actively planning pregnancy, pregnant, or immediately post-pregnancy
To be eligible to access fully subsidised continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) products through the CGM Initiative as part of the NDSS:
- the person is expected to benefit clinically from the use of CGM or Flash GM; and
- the person or family/carer has the willingness and capability to use CGM or Flash GM; and
- the person or family/carer has the commitment to actively participate in a diabetes management plan which incorporates CGM or Flash GM.
In addition, the person must meet the criteria in one of the following categories:
Part A – Pregnancy Planning
The woman with type 1 diabetes is considered as actively planning pregnancy and should be having regular engagement with pre-conception care services such as an endocrinologist, diabetologist and/or specialist physician, ideally at least every 6-8 weeks and more frequently if there is sub-optimal glycaemic control. A health professional authorised to assess and certify eligibility to access the CGM Initiative for an initial 6-month period on the basis of the person seeking active pre-pregnancy care and committing to regular engagement with the pre-conception care service provider.
If at the end of the initial 6-month period the pre-conception care is continuing, an authorised health professional may certify eligibility for a further 6-month period. A maximum of two, 6-month access periods (up to a maximum period of 12 months in total) may be authorised.
Part B – Pregnant or Immediately Post Pregnancy
The woman with type 1 diabetes has a confirmed pregnancy and is regularly engaging with a health professional such as an endocrinologist, diabetologist and/or specialist physician. An authorised health professional may certify eligibility that will continue until 3 months after the expected date of birth of the baby.
Part A: Pregnancy planning
Up to 12 months (initial period of 6 months with a subsequent period of an additional 6 months on confirmation that pre-pregnancy care is continuing).
Part B: Pregnant or Immediately Post Pregnancy
From when the pregnancy is confirmed, until 3 months after the expected or actual date of birth of the baby.
In the event of a pregnancy loss, the currently approved period of CGM and Flash GM access will continue unchanged. In this event, the person may reapply for pregnancy planning status at any time.
At least 1 month prior to the completion of either the ‘pregnancy planning’ or ‘post–pregnancy’ periods, the person will receive a notification via SMS or email, advising them that their access period is ending soon and that they should consult their authorised health professional in relation to future access, or transitioning to alternative arrangements for finger prick blood glucose checks.
For more information read the Frequently asked questions: Continuous Glucose Monitoring Initiative.
Find the Continuous and Flash Glucose Monitoring Access form for type 1 diabetes; pregnancy planning, pregnancy or immediately post pregnancy.
Health professionals authorised to certify eligibility
Health professionals authorised to assess eligibility and certify (sign) Continuous and Flash Glucose Monitoring Access forms must be actively involved in the management and care of women with type 1 diabetes during pregnancy planning, pregnancy and immediately post pregnancy. These authorised health professionals are registered or credentialled to practice as a:
- Nurse practitioner
- Credentialled diabetes educator.
General practitioners, physicians and practice nurses are not authorised to certify Continuous and Flash Glucose Monitoring forms for women with type 1 diabetes during pregnancy planning, pregnancy and immediately post pregnancy.
For more information download a copy of Health professionals authorised to certify access to the CGM Initiative through the NDSS.
After an initial 12 months eligibility for pregnancy planning—supporting documentation is required for an extension of access
There may be exceptional circumstances for an extension of this timeframe that will be considered on a case-by-case basis, noting these will be:
- considered by an appropriately constituted expert panel established by Diabetes Australia that will provide a recommendation to the Department of Health; and
- the Department of Health will be the deciding body for these cases.
Any extension to the pre-pregnancy period will be considered on a case-by-case basis and require documented evidence of exceptional circumstances—such as that the person has been referred to fertility services for assessment.
Your application for an extension of access to CGM and Flash GM products after the initial 12 months requires supporting documentation (on letterhead):
- from both your diabetes health professional (authorised to certify CGM Initiative applications) and your fertility specialist, obstetrician / gynaecologist, confirming that you are continuing to plan pregnancy;
- with your first name, last name and date of birth;
- with the date you were referred to or first attended fertility specialist services;
- including confirmation of your ongoing fertility assessment or management.
Your application for an extension of access to CGM and Flash GM products for a further six-month period, are considered on a case-by-case basis. At the end of this six-month period, further six-month extensions may be granted subject to the same documentation being provided.
To learn more about submitting an application for an extension to access to CGM and Flash GM products, please contact the NDSS Helpline on 1800 637 700.